The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist

BACKGROUND: For the management of venous thromboembolism (VTE), providing anticoagulant therapy within the therapeutic range has been a major challenge, as conventional therapy with unfractionated heparin (UFH) and vitamin K antagonist (VKA) requires frequent laboratory monitoring and dose adjustmen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Clin Risk Manag
Main Authors: Shimizu, Kazuhiro, Iiduka, Takuo, Sato, Shuji, Kiyokawa, Hajime, Nakagami, Takahiro, Mikamo, Hiroshi, Kawazoe, Masayo, Takahashi, Mao, Noro, Mahito
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5827747/
https://ncbi.nlm.nih.gov/pubmed/29503557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S153517
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados